Buyers Say Gleevec Antitrust Suit Should Proceed
A proposed class of purchasers asked a Massachusetts federal court Thursday to keep alive its antitrust suit over Novartis Pharmaceuticals Corp.'s leukemia drug Gleevec, saying the company's patent application and infringement...To view the full article, register now.
Already a subscriber? Click here to view full article